Cargando…
Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin
BACKGROUND: COVID-19 has been associated with a high prevalence of myocardial injury and increased cardiovascular morbidity. Copeptin, a marker of vasopressin release, has been previously established as a risk marker in both infectious and cardiovascular disease. METHODS: This prospective, observati...
Autores principales: | Kaufmann, Christoph C., Ahmed, Amro, Kassem, Mona, Freynhofer, Matthias K., Jäger, Bernhard, Aicher, Gabriele, Equiluz-Bruck, Susanne, Spiel, Alexander O., Vafai-Tabrizi, Florian, Gschwantler, Michael, Fasching, Peter, Wojta, Johann, Giannitsis, Evangelos, Huber, Kurt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592075/ https://www.ncbi.nlm.nih.gov/pubmed/34782921 http://dx.doi.org/10.1007/s00392-021-01970-4 |
Ejemplares similares
-
Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin
por: Kaufmann, C K, et al.
Publicado: (2021) -
Red Cell Distribution Width Upon Hospital Admission Predicts Short-Term Mortality in Hospitalized Patients With COVID-19: A Single-Center Experience
por: Kaufmann, Christoph C., et al.
Publicado: (2021) -
Association of Interleukin-32 and Interleukin-34 with Cardiovascular Disease and Short-Term Mortality in COVID-19
por: Kaufmann, Christoph C., et al.
Publicado: (2023) -
Copeptin Predicts Mortality in Critically Ill Patients
por: Krychtiuk, Konstantin A., et al.
Publicado: (2017) -
Cost analysis of early discharge using combined copeptin/cardiac troponin testing versus serial cardiac troponin testing in patients with suspected acute coronary syndrome
por: Reinhold, Thomas, et al.
Publicado: (2018)